BioInvent International AB (OSTO:BINV) Net Interest Income : kr0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BioInvent International AB Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. BioInvent International AB's net interest income for the three months ended in Mar. 2024 was kr0.00 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.00 Mil.

BioInvent International AB Net Interest Income Historical Data

The historical data trend for BioInvent International AB's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInvent International AB Net Interest Income Chart

BioInvent International AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Interest Income

Get a 7-Day Free Trial

-0.42

-0.31

-0.25

8.42

39.97

BioInvent International AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Interest Income	Get a 7-Day Free Trial															-	-	-	-	-

BioInvent International AB Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

BioInvent International AB Net Interest Income Related Terms

Thank you for viewing the detailed overview of BioInvent International AB's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BioInvent International AB (OSTO:BINV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInvent International AB (OSTO:BINV) » Definitions » Net Interest Income

Comparable Companies

Traded in Other Exchanges

0H22:UK BIX:Germany

Address

Ideongatan 1, The Gamma Building, Lund, SWE, SE-223 70

Website

https://www.bioinvent.com

BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's own clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.

BioInvent International AB (OSTO:BINV) Headlines

No Headlines